Showing 201 - 220 results of 129,020 for search '(( i d decrease ) OR ( 5 ((step decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 2.09s Refine Results
  1. 201
  2. 202
  3. 203
  4. 204

    Proteasome activity was decreased in the <i>myc-rpt6-S119A</i> mutant. by Esther Magdalena Marquez-Lona (4183126)

    Published 2017
    “…The mean ± SEM rate of Suc-LLVY-AMC cleavage is decreased in the <i>myc-rpt6-S119A</i> mutant compared to the WT and <i>myc-rpt6-S119D</i> strains. …”
  5. 205
  6. 206

    Inhibition of IL-17A at tumor sites decreases the intratumoral microvessel density. by Keiji Hayata (277090)

    Published 2013
    “…Data are presented as means ± SE (<i>n</i> = 5). *<i>P</i><0.05, Student's <i>t</i> test. …”
  7. 207
  8. 208
  9. 209
  10. 210
  11. 211

    Repetitive stress induces a decrease in sound-evoked activity. by Ghattas Bisharat (20706928)

    Published 2025
    “…The reduction in activity was particularly striking at moderate sound intensities (mean ± SE, 1-way ANOVA, F = 14.24, <i>p</i> = 1.0 × 10<sup>−13</sup> and <i>t</i> test for each level: 20 dB <i>p</i> = 8.4 × 10<sup>−05</sup>, 30 dB <i>p</i> = 1, 40 dB <i>p</i> = 0.350 dB <i>p</i> = 4.9 × 10<sup>−12</sup>, 60 dB <i>p</i> = 2.4 × 10<sup>−15</sup>, 70 dB <i>p</i> = 1.5 × 10<sup>−05</sup> all corrected for multiple comparisons. …”
  12. 212
  13. 213
  14. 214

    Eltrombopag markedly decreases levels of ROS in MOLM14 cells. by Anna Kalota (7415)

    Published 2015
    “…B) Graphic presentation of ROS levels measured by flow cytometry in cells treated with E (5 μM) or DPI (25 μM), an inhibitor of NADPH oxidase known to decrease an intracellular level of ROS, or untreated (CTR) cells. …”
  15. 215
  16. 216
  17. 217
  18. 218
  19. 219
  20. 220

    Decreased Serum Level of miR-146a as Sign of Chronic Inflammation in Type 2 Diabetic Patients by Lucy Baldeón R. (674016)

    Published 2014
    “…</p><p></p><p></p><p>The serum levels of miR-146a were significantly reduced in T2D patients as compared to these non-diabetic, but obese/dyslipidemic control group (mean patients 0.61, mean controls set at 1; p = 0.042), those of miR-155 were normal.…”